Dare Bioscience, Inc (DARE) Stock Price

0.7734 ▲ +0.0012 (+0.16%)
Open: 0.79 Vol: 68.97K Day's range: 0.7601 - 0.7904 Oct 09, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DARE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.76▲ 0.77▲ 0.78▲ 0.80▼ 0.78▼
MA10 0.79▼ 0.80▼ 0.81▼ 0.81▼ 0.85▼
MA20 0.82▼ 0.82▼ 0.83▼ 0.79▼ 1.37▼
MA50 0.84▼ 0.84▼ 0.82▼ 0.89▼ 1.71▼
MA100 0.83▼ 0.81▼ 0.79▼ 1.42▼ 2.24▼
MA200 0.79▼ 0.78▲ 0.80▼ 1.68▼ 4.70▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.008▼ -0.009▼ -0.010▼ 0.011▲ -0.052▼
RSI 35.986▼ 37.987▼ 39.035▼ 42.288▼ 35.443▼
STOCH 5.197▼ 5.197▼ 9.726▼ 57.980     7.625▼
WILL %R -74.265     -74.265     -74.265     -59.620     -94.248▼
CCI -52.206     -67.555     -91.339     -74.217     -53.766    
Latest Filters Detected On DARE
▲ GAP $DARE Open Gap Up %2 Set Alert
CDL $DARE Matching Low Candlestick Pattern Detected Set Alert
Dare Bioscience, Inc News
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
Thursday, October 08, 2026 02:15 AM
Annie Thurman, MD, FACOG, Medical Director of Daré Bioscience, will present “An Open-Label, Single-Dose, Randomized, Parallel-Cohort Study of the Safety and Relative Bioavailability of Topical ...
Daré Bioscience, Inc.: Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Monday, September 28, 2026 09:09 AM
New U.S. patent expands intellectual property foundation for DARE-HPV, a potential first-in-category treatment targeting persistent high-risk HPV infection DARE-HPV Phase 2 study underway with topline ...
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Monday, September 28, 2026 05:20 AM
New U.S. patent expands intellectual property foundation for DARE-HPV, a potential first-in-category treatment targeting persistent high-risk HPV infection DARE-HPV Phase 2 study underway with topline ...
DARE historical stock data
date open high low close volume
09/10/26 0.79 0.7904 0.7601 0.7734 68,968
08/10/26 0.7862 0.80 0.755 0.7722 165,741
07/10/26 0.8143 0.8194 0.79 0.79 113,070
06/10/26 0.83 0.88 0.83 0.8331 88,343
05/10/26 0.833 0.8689 0.8308 0.8431 157,134
02/10/26 0.869 0.8775 0.8224 0.8428 146,561
01/10/26 0.86 0.8701 0.83 0.851 135,127
30/09/26 0.80 0.88 0.7683 0.8533 277,625
29/09/26 0.7869 0.8671 0.7356 0.815 639,715
28/09/26 0.79 0.816 0.7012 0.75 696,829
Quote Details
52wk Low:0.69
52wk High:3.78
Vol:68.97K
Avg Vol(3m):8.2M
1Y Chng:-61.90%
1M Chng:+5.22%
Add to Watch List
More Information
Index US Composite
Market Cap. 15.19M